Furthermore, a recent phase IIb randomized trial comparing omega-3 supplements to placebo in prostate cancer patients pre-prostatectomy reported no difference in cancer proliferation (measured by Ki-67 expression) between groups (158). This evidence concerns the gene MKI67 and prostate carcinoma.